Since the start of 2026, the S&P 500 (^GSPC -0.38%) has generated total returns, aka price appreciation with dividends reinvested, of around 14% well above historical averages.
However, plenty of stocks have beaten the S&P 500 this year, and not just the hottest names in tech. In fact, there’s one stock in particular, one that may not exactly scream “cutting edge,” that has crushed it thus far in 2026, with total returns of more than 24%.
The stock? Altria Group (MO -0.88%), America’s largest tobacco company and purveyor of popular brands such as Marlboro and Skoal, as well as the nicotine pouch brand On! The question now is whether Altria Group’s shares will remain one of the top-performing high yield dividend stocks.
Image source: Getty Images
Altria Group has smoked the S&P 500 in 2026
At the start of 2026, investors were mixed on this Big Tobacco stock. At the time, concerns ran high about Altria’s ability to adapt to changing nicotine and tobacco consumption habits. Namely, investors were concerned about the company’s falling market share in smokeless tobacco and oral nicotine products.
As these products continue to gain or sustain usage rates, while cigarette smoking rates in the United States keep declining, Altria’s future hinges heavily on the company making a successful smokeless transformation, much like its former subsidiary, Philip Morris International, has successfully accomplished.
However, during much of early to mid 2026, these concerns took a back seat. For one, due to better-than-feared quarterly results. Tobacco stocks in general also performed well during this time, on growing confidence in the industry’s smokefree pivot, which inspired some institutional investors who had shunned the sector to reenter major stocks in the space.
Trading for as much as $77.06 per share in 2026, Altria tumbled back to the mid-$60s per share in August, on the heels of the company’s Q2 2026 earnings release on July 30.
Recent pullback highlights long-term risks
For the quarter, Altria reported just 1.2% net revenue growth, with sales net of exice taxes rising to $5.35 billion. GAAP earnings came in at $1.37 per share, down 2.8% from the prior year’s quarter, and falling short of analyst estimates.
Despite declining domestic cigarette usage, Altria has continued to raise earnings and, in turn, its dividend, thanks to cigarette price hikes and growth from its smokeless products. However, price elasticity with cigarettes may only go so far. While demonstrating some success with products like On!, this still pales in comparison to the success of Philip Morris International’s Zyn nicotine pouches.
Since August, shares have inched higher, thanks to an announced 4.7% dividend raise and news of a contract manufacturing agreement with Philip Morris International that could help utilize excess production capacity .
Trading for 12 times forward earnings, and with a 6.4% forward dividend yield,Altria still seems cheap. Coupled with its high dividend and strong 2026 performance, it may still seem like a winner. However, this stock could still prove risky for the long-term health of your portfolio. If the company’s earnings gambit starts to fail, earnings could take a dive, threatening the stock’s Dividend King status and turning this deep-value winner into a yield-and-value trap.
